Clinical trials with ALS patients showed that Riluzole lengthens survival by several months, and may have a greater survival benefit for those with a bulbar onset.
Studies of ASL patients show that Riluzole can keep them alive several months longer . It may be more helpful for patients with a bulbar onset.